Who we are

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

Read more
Share price
12.25
Read more
Our latest reports
All Reports

Latest news

Edison issues update on e-Therapeutics (ETX)

Non Regulatory Announcement

Partnering & Collaboration

e-therapeutics is presently seeking development and commercialisation partners for both its clinical and preclinical assets.

For more information on our licensing opportunities please contact bd@etherapeutics.co.uk